Take That Myriad!!

Below are words from our fearless leader, Sue Friedman, on the amazing UNANIMOUS decision of the Supreme Court against gene patenting, specifically against Myriad’s patents on the BRCA1 and 2 genes.

“Breaking News!

 Today the United States Supreme Court made history when it unanimously ruled that the Myriad Genetics’ patents on the BRCA1 and BRCA2 genes were invalid.

 FORCE agrees with the Court that genes – as products of nature – should not be patented. FORCE filed an amicus brief in support of the ACLU and testified to the Patent and Trademark Office about the burden that gene patents place on members of our community.

Specifically, the Court stated that “In this case … Myriad did not create anything. To be sure, it found an important and useful gene, but separating that gene from its surrounding genetic material is not an act of invention.”

So what does this mean for our community?

  • It paves the way for other companies to test for mutations on these genes and in fact companies have already stepped forward to offer BRCA testing at a lower cost than Myriad’s test. FORCE will be compiling a list of labs offering BRCA testing.
  • Patients will now have the opportunity to get a second opinion to confirm their genetic test results prior to making life altering preventive surgery decisions.
  • More women (and men) will have access to potentially life-saving genetic information because competition has lowered the cost of these genetic tests.
  • No single company will be able to prevent others from conducting testing and research on the BRCA genes.
  • As more people learn their risk for cancer and their genetic status, this could accelerate clinical trial participation and hereditary cancer research.
We applaud this decision and believe that one barrier to personalized medicine, testing, hereditary cancer research, and better prevention and treatment options has been surmounted with this ruling.
FORCE recommends people consult with an expert in cancer geneticsbefore and after genetic testing for cancer risk. You can visit ourwebsite to learn more about genetic counseling and testing, to find a genetics expert in your area, or to learn about risk management options.”


  1. The Supreme Court’s landmark ruling that human genes are not patentable has set the stage for a new era of access to genetic information. Next, we must fill the information gap left by restricted data access and free our data! Free the Data! is a grass-roots campaign that will create an open, searchable database of genetic information allowing for better diagnosis and care, while protecting patient privacy. Share your BRCA test results or join the campaign to support data access at http://www.free-the-data.org

    1. A professor at UCSD actually created free-the-data.org that deposits de-identified patient data to a publicly available database owned by the NIH, so patients can actually report their own BRCA mutation so other researchers can have it

Leave a Reply

Fill in your details below or click an icon to log in:

WordPress.com Logo

You are commenting using your WordPress.com account. Log Out /  Change )

Google+ photo

You are commenting using your Google+ account. Log Out /  Change )

Twitter picture

You are commenting using your Twitter account. Log Out /  Change )

Facebook photo

You are commenting using your Facebook account. Log Out /  Change )


Connecting to %s